Arterra Bioscience S.p.A. (BIT:ARBS)

Market Cap	18.91M +23.5%
Revenue (ttm)	4.70M +34.8%
Net Income	2.01M +65.7%
EPS	0.30
Shares Out	6.66M
PE Ratio	9.43
Forward PE	n/a
Dividend	0.13 (4.58%)
Ex-Dividend Date	May 4, 2026

Volume	3,000
Open	2.830
Previous Close	2.830
Day's Range	2.790 - 2.840
52-Week Range	2.260 - 3.580
Beta	0.64
Analysts	n/a
Price Target	5.30 (+86.62%)
Earnings Date	Jun 26, 2026

About Arterra Bioscience

Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. The company develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Napoli, Italy.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 36
• Stock Exchange: Borsa Italiana
• Ticker Symbol: ARBS

Financial Performance

In 2025, Arterra Bioscience's revenue was 4.70 million, an increase of 12.74% compared to the previous year's 4.17 million. Earnings were 2.01 million, an increase of 50.09%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 17, 2026

Data Sources Report a data error